Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Operating Expenses (2016 - 2025)

Rockwell Medical's Operating Expenses history spans 16 years, with the latest figure at $3.7 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 12.97% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $14.0 million, down 0.67%, while the annual FY2025 figure was $14.0 million, 0.67% down from the prior year.
  • Operating Expenses reached $3.7 million in Q4 2025 per RMTI's latest filing, up from $3.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $6.1 million in Q2 2021 to a low of $2.9 million in Q4 2023.
  • Average Operating Expenses over 5 years is $4.1 million, with a median of $3.7 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: skyrocketed 35.79% in 2021, then plummeted 39.27% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $5.3 million in 2021, then decreased by 25.1% to $3.9 million in 2022, then dropped by 27.11% to $2.9 million in 2023, then grew by 15.27% to $3.3 million in 2024, then increased by 12.97% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Operating Expenses are $3.7 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025).